Page 771 - Coronavirus Vaccine

Putin says India, China may start making Russia's Sputnik V Covid vaccine

Putin also proposed the creation of a vaccine research centre for BRICS countries

Pfizer vaccine's -70 degree storage norm tough for most nations: V K Paul

Limited number of doses would not be enough to meet India's demand, adds Niti Aayog member

Delhi govt asks Centre to let it shut markets as coronavirus cases spike

Seeks Centre's permission for localised curbs in hotspots and marketplaces; number of guests at weddings may be capped at 50 from 200 currently

Pfizer, Moderna: How 2 firms sprinted ahead in the race for a Covid vaccine

Both companies have reported preliminary findings of more than 90% effectiveness - an unexpectedly high rate - raising hope for an end to the pandemic

Moderna's Covid-19 vaccine may come to India through govt route

Players like Indian Immunologicals willing to partner US firm to manufacture here

Top headlines: Vaccine unlikely before mid-2021, few takers for debt recast

The Central bank has set up an Innovation Hub for the financial sector, last week, Trump asked his senior advisers whether he had options to attack Iran, this and more in today's top headlines

Indian experts hail 'promising' mRNA vaccine for Covid-19 treatment

mRNA (messenger RNA) vaccines trick the body into producing some of the viral proteins itself

Indices end at yet another peak, Sensex up 315 pts; BSE Midcap outperforms

All that happened in the markets today

India Coronavirus Dispatch: Has the Aarogya Setu app been effective?

How migrant workers are adapting after Covid, curbs on Chhath Puja in Delhi and Bihar, and some masks may cause skin problems-news on how the country is coping with the pandemic

UK orders five million doses of Moderna vaccine, eyes spring arrival

Britain had previously secured supply deals for a total of 350 million vaccine doses from six different suppliers, including Pfizer Inc

Watch: Are we on track to checkmate coronavirus pandemic in 2021?

Coronavirus vaccine update: World Health Organisation (WHO) director-general A G Tedros has said that a vaccine by itself will not stop coronavirus pandemic. He explained that a vaccine will complement the other tools we have, but will not replace them. The statement has come at a time time when US-based biotech giants Moderna claimed its vaccine is 94.5% effective. So, taking both claims into account, can we say that we are on track to checkmate the pandemic by 2021?

Over 100 scientists join hands with UN to bust Covid-19 vaccine myths

Globally, the initiative is supported by scientists who are involved in the race of coronavirus vaccine development across the world's top institutes

World Coronavirus Dispatch: US stocks at new high over Moderna vaccine data

Hungary and Poland block EU stimulus package, Citi says successful vaccines will see dollar plummet, No virus protection for jailed elderly Taxes and other pandemic-related news across the globe

Telangana coronavirus update: State reports 952 new Covid-19 cases

Telangana reported 952 new cases of novel coronavirus on Monday, taking the active caseload to 13,732

With 29,163 new coronavirus cases, India's tally mounts to 8.87 million

With 29,163 new coronavirus infections and 449 more Covid-19 fatalities in the past 24 hours, India's overall tally and death toll stood at 8,874,290 and 130,519 respectively

We can stop Covid-19: Moderna vaccine success gives world more hope

Moderna's experimental vaccine is 94.5% effective in preventing Covid-19 based on data from a late-stage trial, it said, becoming the second US drugmaker to report results that far exceed expectations

Covid-19 got global attention as it affected rich nations, says TB expert

The sudden focus on Covid-19 has had a significant negative impact on TB because in many countries the Covid-19 response has been built on or has utilised the TB response, says Grania Brigden

Moderna's Covid vaccine 94.5% effective, edges over Pfizer on storage

Its vaccine's temperature requirements give it an edge over Pfizer's for distribution in India

Biological E's Covid-19 vaccine enters Phase I/II trial after DGCI nod

The results of this clinical trial are expected to be available by February 2021, the release said.

Bharat Biotech's Covid-19 vaccine "Covaxin" enters phase-3 trials

On October 2, the company had sought the drug regulator's permission to conduct phase 3 trials